IgEb immune complexes activate macrophages through FcγRIV binding

Nature Immunology

Volumn 8, Issue 7, 2007, Pages 762-771

  Hirano, Masayuki ^a,c   Davis, Randall S ^a,b,d,e   Fine, David W ^a,c   Nakamura, Shugo ^g   Shimizu, Kentaro ^g   Yagi, Hirokazu ^h   Kato, Koichi ^h   Stephan, Robert P ^a,b   Cooper, Max D ^a,c,f  

^a The University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e UNIVERSITY OF TOKYO   (Japan)

^f University of Alabama at Birmingham   (United States)

^g NAGOYA CITY UNIVERSITY   (Japan)

^h UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRK LIKE PROTEIN; FC RECEPTOR; FC RECEPTOR III; FC RECEPTOR IV; IMMUNOGLOBULIN ALLOTYPE; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G2B ANTIBODY; IMMUNOGLOBULIN RECEPTOR; MMUNOGLOBULIN E B; PHOSPHATIDYLINOSITOL 3 KINASE; UNCLASSIFIED DRUG; FCGR3 PROTEIN, MOUSE; FCGR4 PROTEIN, MOUSE; IMMUNOGLOBULIN E;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; ARTICLE; ASTHMA; BONE MARROW CELL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ORTHOLOGY; PHAGOCYTOSIS; PRIORITY JOURNAL; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SKIN ALLERGY; STRAIN DIFFERENCE; T LYMPHOCYTE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; HAMSTER; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; MOUSE MUTANT; PHYLOGENY; PHYSIOLOGY; PROTEIN BINDING; RAT; SEQUENCE HOMOLOGY; SYRIAN HAMSTER; TUMOR CELL LINE;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN-ANTIBODY COMPLEX; CELL LINE, TUMOR; CRICETINAE; IMMUNOGLOBULIN E; MACROPHAGE ACTIVATION; MESOCRICETUS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; PHYLOGENY; PROTEIN BINDING; RATS; RECEPTORS, IGG; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 34250757026     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni1477     Document Type: Article

References (48)

1. Ravetch, J.V. & Kinet, J.P. Fc receptors. Annu. Rev. Immunol. 9 457-492 (1991).
2. Ravetch, J.V. & Clynes, R.A. Divergent roles for Fc receptors and complement in vivo. Annu. Rev. Immunol. 16, 421-432 (1998).
3. Heyman, B. Regulation of antibody responses via antibodies, complement, and Fc receptors. Annu. Rev. Immunol. 18, 709-737 (2000).
4. Qiu, W.Q., de Bruin, D., Brownstein, B.H., Pearse, R. & Ravetch, J.V. Organization of the human and mouse low-affinity FcγR genes: duplication and recombination. Science 248, 732-735 (1990).
5. Davis, R.S. et al. Fc receptor homologs: Newest members of a remarkably diverse Fc receptor gene family. Immunol. Rev. 190 123-136 (2002).
6. Nimmerjahn, F. & Ravetch, J.V. Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 310, 1510-1512 (2005).
7. Ravetch, J.V. & Lanier, L.L. Immune inhibitory receptors. Science 290, 84-89 (2000).
8. van der Pol, W. & van de Winkel, J.G. IgG receptor polymorphisms: Risk factors for disease. Immunogenetics 48, 222-232 (1998).
9. Hibbs, M.L., Hogarth, P.M. & McKenzie, I.F. The mouse Ly-17 locus identifies a polymorphism of the Fc receptor. Immunogenetics 22 335-348 (1985).
10. Davis, R.S., Ehrhardt, G.R., Leu, C.M., Hirano, M. & Cooper, M.D. An extended family of Fc receptor relatives. Eur J. Immunol. 35 674-680 (2005).
11. Mechetina, L.V., Najakshin, A.M., Alabyev, B.Y., Chikaev, N.A. & Taranin, A.V. Identification of CD16-2, a novel mouse receptor homologous to CD16/FcγRIII. Immunogenetics 54, 463-468 (2002).
12. Nimmerjahn, F., Bruhns, P., Horiuchi, K. & Ravetch, J.V. FCγRIV: A novel FcR with distinct IgG subclass specificity. Immunity 23 41-51 (2005).
13. Songyang, Z. et al. SH2 domains recognize specific phosphopeptide sequences. Cell 72, 767-778 (1993).
14. Hazenbos, W.L. et al. Impaired IgG-dependent anaphylaxis and Arthus reaction in FcγRIII (CD16) deficient mice. Immunity 5 181-188 (1996).
15. Shibuya, A. et al. Fcα/μ receptor mediates endocytosis of IgM-coated microbes. Nat. Immunol. 1, 441-446 (2000).
16. Amigorena, S., Salamero, J., Davoust, J., Fridman, W.H. & Bonnerot, C. Tyrosine-containing motif that transduces cell activation signals also determines internalization and antigen presentation via type III receptors for IgG. Nature 358, 337-341 (1992).
17. Nagai, H., Sakurai, T., Inagaki, N. & Mori, H. An immunopharmacological study of the biphasic allergic skin reaction in mice. Biol. Pharm. Bull. 18, 239-245 (1995).
18. Hughes, A.L. Gene duplication and recombination in the evolution of mammalian Fc receptors. J. Mol. Evol. 43, 4-10 (1996).
19. van Hage-Hamsten, M. et al. Associations of Fc epsilon R1-β polymorphisms with immunoglobin E antibody responses to common inhalant allergens in a rural population. Clin. Exp. Allergy 32, 838-842 (2002).
20. Pandey, J.P. Genetic polymorphism of Fc. Science 311, 1376-1377 (2006).
21. Paterson, T., Innes, J., McMillan, L., Downing, I. & Carter, M.C. Variation in IgG1 heavy chain allotype does not contribute to differences in biological activity of two human anti-Rhesus (D) monoclonal antibodies. Immunotechnology 4, 37-47 (1998).
22. Shinkai, Y., Nakauchi, H., Honjo, T. & Okumura, K. Mouse immunoglobulin allotypes: Multiple differences between the nucleic acid sequences at the IgEa and IgEb alleles. Immunogenetics 27, 288-292 (1988).
23. Radaev, S., Motyka, S., Fridman, W.H., Sautes-Fridman, C. & Sun, P.D. The structure of a human type III Fcγ receptor in complex with Fc. J. Biol. Chem. 276, 16469-16477 (2001).
24. Kaneko, Y., Nimmerjahn, F. & Ravetch, J.V. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science 313, 670-673 (2006).
25. Bartlett, W.C., Kelly, A.E., Johnson, C.M. & Conrad, D.H. Analysis of murine soluble FcεRII sites of cleavage and requirements for dual-affinity interaction with IgE. J. Immunol. 154, 4240-4246 (1995).
26. Haczku, A. et al. CD23 deficient mice develop allergic airway hyperresponsiveness following sensitization with ovalbumin. Am. J. Respir. Crit. Care Med. 156, 1945-1955 (1997).
27. Cernadas, M. et al. CD23 and allergic pulmonary inflammation: potential role as an inhibitor. Am. J. Respir. Cell Mol. Biol. 20, 1-8 (1999).
28. Maurer, D. et al. The high affinity IgE receptor (FcεRI) mediates IgE-dependent allergen presentation. J. Immunol. 154, 6285-6290 (1995).
29. Dolovich, J. et al. Late cutaneous allergic responses in isolated IgE-dependent reactions. J. Allergy Clin. Immunol. 52, 38-46 (1973).
30. Holden, C.A. Atopic dermatitis-messengers, second messengers and cytokines. Clin. Exp. Dermatol. 18, 201-207 (1993).
31. Finkelman, F.D., Pearce, E.J., Urban, J.F., Jr. & Sher, A. Regulation and biological function of helminth-induced cytokine responses. Immunol. Today 12, A62-A66 (1991).
32. Butterworth, A.E. Cell-mediated damage to helminths. Adv. Parasitol. 23, 143-235 (1984).
33. Onah, D.N. et al. Mucasal defense against gastrointestinal nematodes: Responses of mucosal mast cells and mouse mast cell pratease 1 during primary strongyloides venezuelensis infection in FcRγ-knockout mice. Infect. Immun. 68, 4968-4971 (2000).
34. James, S.L. & Nacy, C. Effector functions of activated macrophages against parasites. Curr. Opin. Immunol. 5, 518-523 (1993).
35. Oswald, I.P., Wynn, T.A., Sher, A. & James, S.L. Interleukin 10 inhibits macrophage microbicidal activity by blocking the endogenous production of tumor necrosis factor alpha required as a costimulatory factor for interferon gamma-induced activation. Proc. Natl. Acad. Sci. USA 89, 8676-8680 (1992).
36. James, S.L. & Glaven, J. Macrophage cytotoxicity against schistosomula of Schistosoma mansoni involves arginine-dependent production of reactive nitrogen intermediates. J. Immunol. 143, 4208-4212 (1989).
37. Cheever, A.W. A comparative study of Schistosoma mansoni infections in mice, gerbils, multimammate rats and hamsters. li. qualitative pathological differences. Am. J. Trop. Med. Hyg. 14 227-238 (1965).
38. von Lichtenberg, F. & Byram, J.E. Pulmonary cell reactions in natural and acquired host resistance to Schistosoma mansoni. Am. J. Trop. Med. Hyg. 29, 1286-1300 (1980).
39. Sher, A., Correa-Oliveira, R., Hieny, S. & Hussain, R. Mechanisms of protective immunity against Schistosoma mansoni infection in mice vaccinated with irradiated cercariae. IV. analysis of the role of IgE antibodies and mast cells. J. Immunol. 131, 1460-1465 (1983).
40. Aban, J.L. et al. A fatty acid binding protein from Fasciola hepatica induced protection in C57/BL mice from challenge infection with Schistosoma bovis. Vet. Parasitol. 83, 107-121 (1999).
41. Davis, R.S., Stephan, R.P., Chen, C.C., Dennis, G., Jr. & Cooper, M.D. Differential B cell expression at mouse Fc receptor homologs. Int. Immunol. 16, 1343-1353 (2004).
42. Tsutsui, H. et al. IFN-γ-inducing factor up-regulates Fas ligand-mediated cytotoxic activity of murine natural killer cell clones. J. Immunol. 157, 3967-3973 (1996).
43. Takai, T., Li, M., Sylvestre, D., Clynes, R. & Ravetch, J.V. FcR γ chain deletion results in pleiotrophic effector cell defects. Cell 76, 519-529 (1994).
44. Kitaura, J. et al. Evidence that IgE molecules mediate a spectrum of effects on mast cell survival and activation via aggregation of the FcεRI. Proc. Natl. Acad. Sci. USA 100, 12911-12916 (2003).
45. Onishi, M. et al. Applications of retrovirus-mediated expression cloning. Exp. Hematol. 24, 324-329 (1996).
46. Maenaka, K., van der Merwe, P.A., Stuart, D.I., Jones, E.Y. & Sondermann, P. The human low affinity Fcγ receptors IIa, IIb, and III bind IgG with fast kinetics and distinct thermodynamic properties. J. Biol. Chem. 276, 44898-44904 (2001).
47. Campbell, P.A., Canono, B.P. & Drevets, D.A. in Current Protocol in Immunology (eds. Coligan, J. E., Kruisbeek, A.M., Margulies, D.H., Shevach, E.M. & Strober, W) 14.6.1-14.6.13 (John Wiley & Sons, Hoboken, New Jersey, 1996).
48. Strong, P., Townsend, P., Mackay, R., Reid, K.B. & Clark, H.W. A recombinant fragment of human SP-D reduces allergic responses in mice sensitized to house dust mite allergens. Clin. Exp. Immunol. 134, 181-187 (2003).